Will Tech Replace Your Doctor? Weighing Benefits and Risks

It is increasingly difficult to distinguish accurate health information from compelling but false content online. Dhruv Khullar highlights that while there's an abundance of easily generated, engaging content, much of it lacks accuracy, creating a significant challenge for consumers. He notes that there are many ways for information to be wrong, but only a few ways to be right, underscoring the necessity of rigorous verification to ensure accuracy in digital health content.

Dr. Khullar argues that society is inundated with health metrics, often leading to an over-reliance on data that can diminish an individual's ability to listen to their own body. He suggests that while metrics have their place, the most important indicator of health is a qualitative sense of well-being, such as feeling healthy and energized daily. This subjective experience, he believes, should be prioritized alongside objective clinical data to provide a more holistic view of health.

For practical gut health, he recommends increased fiber intake, as an estimated 95% of Americans do not consume enough. This simple dietary adjustment is presented as an evidence-based habit to support a healthy microbiome.

While tracking steps can serve as a positive, tangible motivator for some individuals, Dhruv Khullar cautions against over-reliance on wearable technology. He highlights a potential problem when people depend on devices like sleep trackers to determine if they feel well-rested, suggesting this can disconnect them from their natural physical awareness. Khullar stresses the importance of developing a vocabulary for subjective feelings to complement quantitative tracking, ensuring people remain in touch with their own bodies.

Zack Abbott predicts that genetic engineering, currently perceived as radical, will become a normal aspect of healthcare within 20 years. He points to recent successes in curing diseases like sickle cell anemia as clear evidence of gene editing's profound potential. Abbott explains that natural mutations are a constant biological process, making therapeutic gene interventions a logical progression in human health. He draws a distinction between life-saving medical corrections and the more controversial concept of "designer babies," asserting that the former will lead the path to broader acceptance.

Public perception often harbors wariness towards biotechnology in food, despite its pervasive use in modern food systems. Zack Abbott asserts that the reality is that deliberate decisions can be made to engineer food to be better for consumers. He argues that the goal should shift towards using technology to actively enhance user health, rather than merely optimizing for product appeal or addiction, thereby fostering a more beneficial relationship between consumers and food technology.

Traditional crossbreeding, often driven by aesthetic goals such as achieving a bright red color in tomatoes, inadvertently led to a reduction in nutritional value. Zack Abbott explains that this inefficient form of genetic engineering accidentally removed important micronutrients and phytochemicals. He notes that genetic silencing further contributes to this issue by preventing fruit from continuing to produce essential sugars and polyphenols after harvest, diminishing their nutritional content.

Genetic engineering offers the potential to reactivate specific genes, for example, to improve the flavor and sugar production in foods like tomatoes. Zack Abbott suggests that by enhancing taste, this technology could increase the likelihood of people consuming more fresh produce, thereby improving their diets. He underscores that technology itself is a neutral tool, with its ultimate value determined by the intent and application behind its use.

Zack Abbott contends that consumers do not inherently dislike Genetically Modified Organisms (GMOs); rather, they reject GMOs that offer no direct benefit to them. He points out that the current logic behind many GMOs places all risks on consumers while the benefits accrue to seed producers and farmers. This imbalance means that the choice between non-GMO and GMO options often presents buyers with all the potential risks and no tangible rewards, leading to public skepticism.

He illustrates this with the example of driving a car, an inherently dangerous activity that society accepts due to its immense benefits. Abbott argues that if genetic engineering is deployed responsibly and clearly demonstrates benefits to the end-user, the public's perception and willingness to accept the associated risks will shift positively. This framework suggests that successful integration of advanced biotech hinges on transparently showcasing its advantages while mitigating perceived dangers.